Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue
Early reports suggest tocilizumab and antibody therapies may help severe cases, but researchers say rare outbreaks have left trials underfunded.
- A rare, deadly hantavirus recently struck passengers on the cruise ship MV Hondius near Tenerife Sud, Spain, exposing a critical gap in global health preparedness despite decades of known threat.
- Despite being a known threat for decades, there are no licensed vaccines or treatments available for hantavirus, a gap driven by the virus's relative rarity and limited human-to-human transmission deterring sustained investment.
- In Argentina, researchers tested whether tocilizumab, a rheumatoid arthritis drug, treats hantavirus pulmonary syndrome; four of five patients survived after receiving it alongside traditional care, reported in The Lancet Infectious Diseases.
- María Inés Barría of the Universidad San Sebastián develops antibody treatments, while Jay Hooper of the U.S. Army Medical Research Institute of Infectious Diseases leads vaccine efforts that successfully generated antibodies in early-stage human trials.
- "That is why it is a public health problem," said Barría. Dr. Fernando Tortosa of the National University of Río Negro in Patagonia hopes current attention will strengthen collaboration and provide necessary resources.
31 Articles
31 Articles
Tools to Fight Hantavirus Show Promise Despite Limited Funding
(MedPage Today) -- SANTIAGO, Chile -- When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case...
The Toronto Star
Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue
SANTIAGO, Chile (AP) — When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell
The long-tailed rice pygmy rat, Oligoryzomys longicaudatus, is a natural reservoir of the hantavirus. And especially of the Andes strain, suspected of being responsible for the death of several passengers of a cruise ship. This endemic rodent of South America has long remained poorly known, but the ecological studies conducted since 1995, date of the first case of human infection with hantavirus, allow to plot his portrait-robot and the conditio…
Investigators announced the promising development of drugs against hantavirus pislya spalahu on a cruise linerInaukovtsy to test the drug from autoimmune firewood for the treatment of hantavirus. The results were activated after the infection on cruise ship.
Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue - Regional Media News
SANTIAGO, Chile (AP) - When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case even though it wasn't a novel germ that the world had never seen before, like the virus that caused the coronavirus pandemic. It was a hantavirus, one of a family of viruses that have been known for decades and are thoug…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
